(78) showed that the mRNA levels of PSMA3 and PSMA3-AS1 in CD138+ MM cells were significantly elevated in patients with bortezomib-resistant MM compared with those in patients with bortezomib-sensitive MM. This evidence concerns the gene SDC1 and Miyoshi myopathy.